Lexaria Bioscience Announces $3.5 Million Capital Raise to Advance Drug Delivery Technology
Lexaria Bioscience Corp. has secured $3.5 million through a registered direct offering and concurrent private placement, providing critical funding to advance its DehydraTECH drug delivery platform research and development.
Read the full story



























